Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 8Head & Neck 6Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Stomach Neoplasms 140Esophageal Neoplasms 71Pancreatic Neoplasms 42Esophageal Squamous Cell Carcinoma 25Carcinoma, Non-Small-Cell Lung 24Adenocarcinoma Of Esophagus 23Breast Neoplasms 18Neoplasms 15Colorectal Neoplasms 15Neoplasm Metastasis 14Prostatic Neoplasms 11Ovarian Neoplasms 9Melanoma 9Squamous Cell Carcinoma of Head and Neck 8Lung Neoplasms 8Adenocarcinoma 8Sarcoma 7Colonic Neoplasms 7Biliary Tract Neoplasms 7Small Cell Lung Carcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 5Gastrointestinal Neoplasms 5Gallbladder Neoplasms 5Carcinoma, Hepatocellular 5Uterine Cervical Neoplasms 4Salivary Gland Neoplasms 4Rectal Neoplasms 4Head and Neck Neoplasms 4

Interventions

Oxaliplatin 10Gemcitabine 8Cisplatin 7Hepatectomy 6Fluorouracil 6Radiofrequency Ablation 5Liver Transplantation 5Irinotecan 5Capecitabine 5lenvatinib 4Paclitaxel 4Neoadjuvant Therapy 4Folfox protocol 4Cetuximab 4Aspirin 4tislelizumab 3Surgical Procedures, Operative 3Nivolumab 3Carboplatin 3titanium silicide 2durvalumab 2apatinib 2Trastuzumab 2S 1 (combination) 2Leucovorin 2Lamivudine 2Introns 2Ethiodized Oil 2Drug Therapy 2DNA, Mitochondrial 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Docetaxel × Gastrointestinal × Clear all
NCT01283204 2019-01-29

Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

Yonsei University

Phase 2 Completed
180 enrolled
Gastrointestinal

Recurrence, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡